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Abstract
Background: Retinal neovascularization is a common cause of vision loss in proliferative diabetic retinopathy,
retinopathy of prematurity and age-related macular degeneration. Samul-tang (SMT) is a widely used traditional
herbal medicine in East Asia and is also known as Shimotsu-to in Japanese and Si-Wu decoction in Chinese. This
study was designed to evaluate the inhibitory effect of SMT on retinal pathogenic angiogenesis in a mouse model
of oxygen-induced retinopathy (OIR).
Method: The mice were exposed to a 75 % concentration of oxygen for five days, starting on postnatal day 7
(P7-P12). The mice were then exposed to room air and were intraperitoneally injected with SMT (10 mg/kg or
50 mg/kg) once per day for five days (P12-P16). On P17, we measured retinal neovascularization and evaluated
both the expression of angiogenesis-related proteins and changes in the gene expression level in the mRNA.
Results: SMT reduced the area of the central retina and reduced retinal neovascularization in OIR mice. The protein
array revealed that SMT reduced the level of SDF-1 protein expression. Quantitative real-time PCR revealed that the
HIF-1α, SDF-1, CXCR4 and VEGF mRNA levels in the retinas of OIR mice were elevated compared with those of
normal control mice. However, SMT decreased the levels of HIF-1α, SDF-1, CXCR4 and VEGF mRNA in OIR mice.
Conclusion: We are the first to elucidate that SMT inhibits the retinal pathogenic angiogenesis induced by
ischemic retinopathy in OIR mice. SMT significantly inhibited retinal neovascularization by downregulating HIF-1α,
SDF-1, CXCR4 and VEGF. Based on the results of our study, SMT could be a useful herbal medicine for treating
ischemic retinopathy.
Keywords: Retinal neovascularization, Stromal cell-derived factor 1, Chemokine (C-X-C motif) receptor 4,
Vascular endothelial growth factor, Oxygen-induced retinopathy
Background
Retinal neovascularization, which is the pathological
growth of new blood vessels, is a characteristic feature of
several eye diseases that cause catastrophic loss of vision.
Proliferative diabetic retinopathy, retinopathy of prema-
turity and age-related macular degeneration are the most
common causes of retinal neovascularization [1, 2].
Vascular endothelial growth factor (VEGF) plays a
central pathogenic role in retinal neovascularization
caused by hypoxia-induced retinal damage. Hypoxia in
the retina induces compensatory changes in blood flow,
the overexpression of cytokines and angiogenesis [3, 4].
The activation of VEGF promotes the migration and
proliferation of endothelial cells with the formation of
new blood vessels [5].
The disruption of VEGF signaling is a useful target for
therapeutic interventions, and VEGF antagonists have an
inhibitory effect on angiogenesis [6]. All anti-VEGF
therapies require repeated injections of expensive VEGF
antagonists and only offer a temporary respite from
vascular leakage; thus, such therapies can achieve only
partial clinical success. The lack of efficacy of anti-VEGF
treatments may be caused by the effects of this treat-
ment on the HIF pathway-mediated expression of other
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pro-angiogenic factors, such as stromal cell-derived
factor 1 (SDF-1), platelet-derived growth factor-B (PDGF),
insulin-like growth factor 1 (IGF-1), erythropoietin, and
other factors [7, 8].
Stromal cell-derived factor (SDF)-1 is a member of the
CXC subfamily of chemokines; it was initially cloned from
murine bone marrow and was characterized as a pre-B
cell growth stimulating factor [9]. Two isoforms of this
factor (i.e., SDF-1α/CXCL12a and SDF-1β/CXCL12b)
have been identified. These isoforms are encoded by a
single gene and arise via alternative splicing [10]. CXCR4,
which is a 7-transmembrane spanning G protein-coupled
receptor and a known receptor for SDF-1, induces ex-
travasation, locomotion, invasion, migration, homing, and
cell survival [11, 12]. CXCR4 is selectively expressed in
vascular endothelial cells and is upregulated by the angio-
genic factors basic fibroblast growth factor (bFGF) and
VEGF [13]. SDF-1, which is one of the most important
chemokines induced by ischemia, and CXCR4 regulate
specific steps in new vessel formation, proliferation and
angiogenesis [14, 15].
Samul-tang (SMT), which is known as Shimotsu-to in
Japanese and Si-Wu decoction in Chinese, is a basic
prescription that consists of four herbs. For hundreds of
years in Eastern Asia, SMT has been a traditional treat-
ment for relieving pain, promoting blood circulation,
and improving blood deficiencies, gynecological diseases
and chronic inflammation [16, 17]. The novel pharmaco-
logical activities of SMT, including anti-cancer proper-
ties, anti-inflammatory effects and anti-pruritic activity,
have recently been reported [17]. SMT has also been
used because of its angiogenesis [18] and anti-diabetic
properties [19]. Although retinal neovascularization is
recognized as the hallmark of proliferative diabetic retin-
opathy, the effect of SMT on retinal pathogenic angio-
genesis has not been reported. Therefore, the purpose of
this study was to investigate the effect of SMT on retinal




A standardized SMT powder was kindly provided by Dr.
Hyeun-Kyoo Shin (Korea Institute of Oriental Medicine,
Daejeon, Korea). The formula for SMT consists of a mix-
ture of four herbs, including Angelica gigas (4.6875 g),
Cnidium officinale (4.6875 g), Paeonia lactiflora (4.6875 g),
and Rehmannia glutinosa (4.6875 g). SMT was boiled with
distilled water at 100 °C for 2 h, and the extract was
condensed by freeze-drying (yield: 33.3 %). In a previous
report, HPLC analysis identified that the major compounds
of SMT are 5-hydroxymethyl-2-furaldehyde (5-HMF), albi-
florin, paeoniflorin, ferulic acid, and nodakenin [17].
A mouse model of oxygen-induced retinopathy
Ischemic retinopathy was induced in C57BL/6 mouse
pups, as described previously [20]. On postnatal day 12
(P12), after being exposed to 75 ± 2 % oxygen for five
days (P7-P12), the mice were randomly assigned to one
of three groups: OIR group, SMT-10 (10 mg/kg/day)
and SMT-50 (50 mg/kg/day). The normal control group
(Con) was maintained under room air from birth until
postnatal day 17 (P0 to P17). To minimize the differ-
ences in the pups’ weights, one mouse nursed 6–8 pups,
and low-weight pups were discarded from the data sets.
In humans, the recommended daily dose of SMT is
approximately 18.75 g of dried herbs [21], which is
equivalent to 6.24 g of the SMT extract (yield = 33.3 %).
Considering a mean body weight of 60 kg for an adult,
this dose for humans is equivalent to 104 mg/kg of SMT
extract. We chose two doses of SMT (10 and 50 mg/kg)
based on the minimum human equivalent dosage of raw
herbs. The SMT was dissolved in saline, and 100 μl of
this solution was injected intraperitoneally once per day
for five days (P12-P16). The OIR and normal control
groups were injected with the saline solution for five
days. On P17, after five days of intraperitoneal injections,
the mice were anesthetized and sacrificed. These experi-
ments were repeated four times using four animals in
each group. All experiments that used animals were
approved by the Korea Institute of Oriental Medicine
Institutional Animal Care and Use Committee.
Fluorescein-dextran microscopy
On P17, the mice were deeply anesthetized using zolaze-
pam (Zoletil, Virbac, Carros, France). PBS containing
fluorescein-dextran (FD40S, Sigma, MO, USA) was sub-
sequently circulated through the left ventricle. The ret-
inas were dissected, flat mounted onto glass slides and
viewed using fluorescence microscopy (BX51, Olympus,
Tokyo, Japan). Quantification of the non-perfusion area
was performed as described previously [22]. Briefly,
images of the retina were taken at 40× magnification
and imported into Adobe Photoshop. The area of non-
perfusion in the center of the retina was quantified by
comparing the number of pixels in the affected areas
with the total number of pixels using the ImageJ soft-
ware (NIH, MD, USA).
Lectin staining
The retinas were incubated with 1 % bovine serum albu-
min and 5 % Triton X-100 in PBS for 3 h at room
temperature. The retinas were washed 3 times with PBS
and incubated overnight at 4 °C with biotin-conjugated
isolectin B4 from Bandeiraea simplicifolia (Sigma-Aldrich,
MO, USA) diluted 1:50 in PBS. The retinas were washed
with 0.05 % Tween 20 in PBS, followed by incubation with
streptavidin TRITC (1:500, Serotec, Oxford, UK) for 4 h at
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37 °C. The retina was flat mounted and viewed using
fluorescence microscopy (BX51, Olympus, Tokyo, Japan).
The neovascular tufts in the retina were measured in the
same way as the non-perfusion area.
Angiogenesis-related protein array
To analyze the angiogenesis-related protein profiles in
the retinas, a mouse angiogenesis array (R&D Systems,
MN, USA) was performed following the manufacturer’s
protocol. Briefly, the pooled mice retinas (n = 3) were
homogenized in PBS using protease inhibitors and cen-
trifuged at 10,000 × g for 5 min, and the total protein
concentrations were quantified. The lysates were added to
a membrane spotted with antibodies against angiogenesis-
related proteins. After being incubated overnight at 4 °C,
the membranes were treated with streptavidin-horseradish
peroxidase and visualized using an enhanced chemilu-
minescence detection system (Amersham Bioscience, NJ,
USA) on an image analyzer (LAS-3000, Fujifilm, Tokyo,
Japan). Optical density measurements were obtained using
the ImageJ software (NIH, MD, USA).
Real-time PCR analysis
Total RNA was isolated using the TRIzol reagent
(Invitrogen, CA, USA), and 0.5 μg of total RNA was re-
verse transcribed into cDNA with the PrimeScript First
Strand cDNA Synthesis kit (Bio-Rad, CA, USA). Real-time
quantitative PCR was performed with specific primers for
HIF-1α, SDF-1, CXCR4, VEGF and GAPDH using an iQ5
Continuous Fluorescence Detector System (Bio-Rad, CA,
USA). The sequences of the primers were as follows:
for HIF-1α, 5′-GTCGGACAGCCTCACCAAACAG-3′
and 5′-TAGGTAGTGAGCCACCAGTCATCCAAGGAA-
3′; for VEGF, 5′-TCCTCCTATCTCCACCACCTATCC-3′
and 5′-GACCCAGCCAGCCATACCC-3′; for SDF-1, 5′-
GTCCACCTCGGTGTCCTCTT-3′ and 5′-GGGCACAG
TTTGGAGTGTTG-3′; for CXCR4, 5′-TACCTCGCTA
TTGTCCACGC-3′ and 5′-GTGCACGATGCTCTCGAA
GT-3′; for GAPDH, 5′-AACGACCCCTTCATTGAC-3′
and 5′-TCCACGACATACTCAGCAC-3′. All real-time
PCR experiments were run in triplicate. The mRNA levels
of GAPDH were determined for the normalization of the
HIF-1α, SDF-1, CXCR4 and VEGF mRNA expression
values using the iQ5 optical system software (Bio-Rad, CA,
USA).
Statistical analysis
The results were expressed as the mean ± SE and analyzed
using one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparison tests or using unpaired
Student’s t-test. All analyses were performed using the
Prism 6.0 software (GraphPad Software, San Diego, CA,
USA).
Results
Effect on retinal neovascularization
The OIR mice that were treated with SMT exhibited a
significant decrease in the pathological changes that oc-
curred during ischemic retinopathy. As shown in Figs. 1
and 2, SMT reduced the area of vascular obliteration of
the central retina and prevented pathogenic retinal neo-
vascularization compared with the OIR group on P17.
Fig. 1 The effect of SMT on retinal neovascularization in OIR mice. a The retinal blood vessels were visualized via fluorescein angiography using
FITC-dextran. Con, normal control mice; OIR, saline-treated OIR mice; SMT-10, OIR mice treated with 10 mg/kg of SMT; and SMT-50, OIR mice
treated with 50 mg/kg of SMT. b The quantification results are expressed as the percentage of the central non-perfused area within the total
retinal area. The values in the bar graph represent the mean ± SE (n = 5; *p < 0.05 vs. saline-treated OIR mice)
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Mice that were treated with 10 mg/kg of SMT failed to
exhibit a significant change in the area of non-perfusion
in the center of the retina, but 50 mg/kg of SMT signifi-
cantly decreased the non-perfused area compared with
the OIR group (Fig. 1). In addition, both doses of SMT
significantly reduced the formation of neovascular tufts
(by 31.1 and 49.4 %, respectively) compared with the OIR
group (Fig. 2). Consequently, SMT helped prevent the
pathogenic retinal neovascularization during ischemic
retinopathy.
Effect on the protein expression of angiogenesis-related
factors
SMT decreased the expression of pro-angiogenic factors
(i.e., endostatin, IGFBP-2, SDF-1 and serpin E1) in a
dose-dependent manner compared with saline-treated
OIR mice (Fig. 3). In addition, anti-angiogenic factors,
such as CXCL4, were significantly downregulated by
SMT. This result demonstrates that SMT exerts an in-
hibitory effect on angiogenesis by downregulating the
expression of endostatin, IGFBP-2, SDF-1 and serpin E1.
The upregulation of CXCL4 in the OIR group may have
been a defense mechanism against angiogenesis.
Consistent with a previous study [20], the VEGF protein
was not detected in the angiogenesis protein array. In
addition, HIF-1α and CXCR4 could not be tested using
this array. Thus, we further investigated changes in the
gene expression level of HIF-1α, VEGF and CXCR4 at
the mRNA.
Effects on expression of HIF-1α, SDF-1, CXCR4 and VEGF
mRNAs
The retinal mRNA expression levels of HIF-1α, SDF-1,
CXCR4 and VEGF were examined using real-time PCR.
In OIR mice, the HIF-1α, SDF-1, CXCR4 and VEGF
mRNA levels were elevated compared with those of nor-
mal control mice. However, mRNA levels of HIF-1α,
SDF-1, CXCR4 and VEGF were significantly decreased
in SMT-treated OIR mice (Fig. 4).
Discussion
The OIR model is widely used to study the pathological
angiogenesis that results from ischemia. In the OIR
model, the exposure of pups to hyperoxia results in
endothelial cell death and vaso-obliteration, which leads
to physiological hypoxia [23]. When the mice are
returned to room air (P12-P17), the retina becomes
Fig. 2 The effect of SMT on retinal neovascular tufts in OIR mice. a The retinal neovascular tufts were visualized using isolectin B4 staining. Con,
normal control mice; OIR, saline-treated OIR mice; SMT-10, OIR mice treated with 10 mg/kg of SMT; and SMT-50, OIR mice treated with 50 mg/kg
of SMT. b Quantification results are expressed as neovascular tufts on the retina surface. The values in the bar graph represent the mean ± SE
(n = 5; *p < 0.05 vs. saline-treated OIR mice)
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Fig. 3 Expression of retinal angiogenesis-related proteins in OIR mice. (a) Proteins whose expression was modulated in retinas treated with SMT are
indicated by numbers. Con, normal control mice; OIR, saline-treated OIR mice; SMT-10, OIR mice treated with 10 mg/kg of SMT; and SMT-50, OIR
mice treated with 50 mg/kg SMT. 1: Endostatin; 2: IGFBP-2, insulin-like growth factor binding protein 2; 3: CXCL4; 4: SDF-1, stromal cell-derived
factor 1; 5: Serpin E1. (b) The levels of pro- and anti-angiogenic factors in the retina were analyzed using protein arrays and quantified using ImageJ
software. The positive controls are located in three corners of the arrays, and the negative control is located in the lower right corner of the arrays
Fig. 4 Real-time PCR analysis of HIF-1α, SDF-1, CXCR4 and VEGF mRNA levels in OIR mice. When compared with normal controls, the relative
expression levels of the HIF-1α (a), SDF-1 (b), CXCR4 (c) and VEGF (d) mRNAs were markedly increased in the retinas of OIR mice and dramatically
reduced after SMT treatment. Con, normal control mice; OIR, saline-treated OIR mice; SMT-10, OIR mice treated with SMT (10 mg/kg); and SMT-50,
OIR mice treated with SMT (50 mg/kg). The data are shown as the mean ± SE (n = 4; #p < 0.05, ##p < 0.0001 vs. the normal control mice, *p < 0.05
vs. saline-treated OIR mice)
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hypoxic due to the absence of the retinal vasculature;
this hypoxia strongly stimulates pro-angiogenic factors
and results in abnormal neovascularization [23, 24]. In
this study, we investigated whether SMT could inhibit
retinal neovascularization in OIR mice. We demon-
strated that SMT has an inhibitory effect on the expres-
sion of HIF-1α, SDF-1, CXCR4 and VEGF in OIR mice.
Our findings indicate that SMT has anti-angiogenic activ-
ity during pathological retinal neovascularization. In our
array of angiogenesis-related factors, the OIR mice
showed upregulated protein expression of endostatin,
IGFBP-2, CXCL4, SDF-1 and serpin E1. The upregulation
of CXCL4, an anti-angiogenic factor, in OIR may be a
defense mechanism against angiogenesis, and a decrease
of CXCL4 by the SMT is associated with the mechanism
by which CXCL4 inhibits the binding of VEGF [25]. In
proliferative diabetic retinopathy, an increase of anti-
angiogenic factors, such as sVEGFR-1 and TSP-2, may be
a protective mechanism against the progression of angio-
genesis [26]. To elucidate the various signaling molecules
and growth factors involved in the anti-angiogenic effect
of SMT in the OIR mice, we focused on HIF pathway-
mediated expression.
Hypoxia inducible factor (HIF)-1α is an important
oxygen-dependent regulator in both the vaso-obliterative
phase, in which HIF-1α is suppressed, and the neovascu-
larization phase, in which HIF-1α produces angiogenic
factors, such as vascular endothelial growth factor (VEGF)
and stromal cell-derived factor 1 (SDF-1) [27, 28].
Although VEGF is widely recognized as an ideal target
for regulating angiogenesis therapies [29, 30], recent
evidence has suggested that SDF-1 is a key player in
ischemic retinopathies, such as proliferative retinopathy
and retinopathy of prematurity [31]. SDF-1 and CXCR4
are expressed in the ischemic retina and contribute to
the recruitment of bone marrow-derived endothelial
cells to reduce macrophage influx and retinal neovas-
cularization [32]. The SDF-1 expression levels are upreg-
ulated in the vitreous humor in ischemic ocular diseases,
such as proliferative diabetic retinopathy and retinop-
athy of prematurity [33, 34]. Eyes treated with the
CXCR4 inhibitor N-(1-methyl-1-phenylethyl)-N-[((3S)-
1-{2-[5-(4H-1,2,4-triazol-4-yl)-1H-indol-3-yl]ethyl}pyr-
rolidin-3-yl)methyl] amine have significantly less retinal
neovascularization on the surface of the retina [35]. In
addition, several studies have suggested that the SDF-1/
CXCR4 axis regulates VEGF secretion and expression,
thereby promoting VEGF-mediated angiogenesis. The se-
cretion of VEGF is induced by SDF-1/ CXCR4 activation
in several cell lines. The SDF-1/CXCR4 axis augments
VEGF expression at both the mRNA and protein levels,
and the inhibition of SDF-1/CXCR4 signaling reduces
VEGF expression in an in vivo model [28, 36]. Further-
more, SDF-1 and VEGF interact synergistically to
promote vascular endothelial cell functions, such as cell
survival, cell migration and changes in gene expression
[37, 38]. In the retinas of OIR rats, VEGF and SDF-1 act
synergistically to induce angiogenesis. In rats, SDF-1
induces Müller cell activation, thereby stimulating the
secretion of VEGF; in turn, VEGF secretion by the ische-
mic retina increases CXCR4 expression in Müller cells
[28]. Thus, increased levels of SDF-1 have been suggested
to promote the interaction with CXCR4 and activate
VEGF expression in the retina of OIR mice. Therefore,
HIF-1α, SDF-1, CXCR4 and VEGF have been proposed
as targets for treating retinal neovascularization. Our
study demonstrated that SMT prevents retinal neovascu-
larization and reduces the expression of HIF-1α, SDF-1,
CXCR4 and VEGF in OIR mice. These results indicate
that the expression of HIF-1α, SDF-1, CXCR4 and VEGF
is highly correlated with retinal neovascularization and
that the inhibitory effect of SMT on retinal neovasculari-
zation might occur due to the downregulation of both
SDF-1 and CXCR4.
SMT contains A. gigas, C. officinale, P. lactiflora and
R. glutinosa. A. gigas extract and its two major couma-
rins, which were previously identified as decursin and
decursinol angelate, have been demonstrated to exert
inhibitory effects on angiogenesis by reducing VEGF ex-
pression [39, 40]. Extracts of C. officinale with Tabanus
bovinus inhibited the proliferation of glomerular capillary
endothelial cells and reduced neovascular formation in
the chorioallantoic membrane and the rat cornea [41]. P.
lactiflora extracts inhibited the proliferation, migration,
and tube formation ability of human vascular endothelial
cells and reduced vascular density and formation in a
chorioallantoic membrane model system [42]. R. glutinosa
extracts enhanced the migration, mobilization and thera-
peutic angiogenesis of endothelial progenitor cells after
myocardial infarction by activating the SDF-1/CXCR4
cascade [43]. These observations suggest that the preven-
tion of retinal neovascularization by SMT may occur due to
a combination of the effects of these four herbs. However,
the detailed mechanism that underlies the synergistic effects
of SMT on retinal neovascularization remains unknown.
Conclusion
In conclusion, we demonstrated for the first time that
SMT inhibits the retinal pathogenic angiogenesis induced
by ischemic retinopathy in OIR mice. In addition, the
overexpression of HIF-1α, SDF-1, its receptor CXCR4,
and VEGF were significantly inhibited by treatment with
SMT. These observations suggest that SMT regulates a
HIF-1α and acts through an anti-SDF-1/CXCR4 and
anti-VEGF mechanism to prevent retinal pathogenic
angiogenesis. Taken together, these findings indicate that
SMT could be a useful herbal medicine for treating ische-
mic retinopathy.
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